TrialThe Journal of infectious diseases2024

Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis.

Julie M Strizki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.